Publications 2024

Brobak KM, Halvorsen LV, Aass HCD, Søraas CL, Aune A, Olsen E, Bergland OU, Rognstad S, Blom KB, Birkeland JAK, Høieggen A, Larstorp ACK, Solbu MD (2024)
Novel biomarkers in patients with uncontrolled hypertension with and without kidney damage
Blood Press, 33 (1), 2323980
DOI 10.1080/08037051.2024.2323980, PubMed 38606688

Brobak KM, Melsom T, Eriksen BO, Høieggen A, Norvik JV, Solbu MD (2024)
The Association between Urinary Sodium-Potassium Ratio, Kidney Function, and Blood Pressure in a Cohort from the General Population
Kidney Blood Press Res, 49 (1), 184-195
DOI 10.1159/000535977, PubMed 38382490

Halvorsen LV, Søraas CL, Larstorp ACK, Hjørnholm U, Kjær VN, Liestøl K, Aune A, Olsen E, Brobak KM, Bergland OU, Rognstad S, Aarskog NR, Heimark S, Fadl Elmula FEM, Gerdts E, Mo R, Solbu MD, Opdal MS, Kjeldsen SE, Rostrup M, Høieggen A (2024)
Effect of Therapeutic Drug Monitoring on Adherence and Blood Pressure: A Multicenter Randomized Clinical Trial
Am J Hypertens, 37 (10), 826-836
DOI 10.1093/ajh/hpae059, PubMed 38713475

Kjeldsen SE, Elmula FEMF, Fossum E, Høieggen A (2024)
[Not Available]
Tidsskr Nor Laegeforen, 144 (15)
DOI 10.4045/tidsskr.24.0584, PubMed 39692655

Olsen E, Jamerson K, Schmieder RE, Søraas CL, Mariampillai JE, Mancia G, Kjeldsen SE, Heimark S, Mehlum MH, Liestøl K, Larstorp ACK, Halvorsen LV, Høieggen A, Burnier M, Rostrup M, Julius S, Weber MA (2024)
Effects of valsartan vs amlodipine and achieved lower blood pressure on the incidence of end-stage kidney disease: The VALUE Trial
Eur J Intern Med (in press)
DOI 10.1016/j.ejim.2024.12.021, PubMed 39694747

Publications 2023

Kjeldsen SE, Mariampillai JE, Høieggen A (2023)
Uric acid and left ventricular mass in prediction of cardiovascular risk-New insight from the URRAH study
Eur J Intern Med, 114, 45-46
DOI 10.1016/j.ejim.2023.05.016, PubMed 37179137

Mariampillai JE, Halvorsen LV, Larstorp AC, Heimark S, Waldum-Grevbo B, Kjeldsen SE, Nordby G, Stenehjem AE, Berg JP, Høieggen A (2023)
[Diabetes and chronic kidney disease]
Tidsskr Nor Laegeforen, 143 (12)
DOI 10.4045/tidsskr.22.0822, PubMed 37668137

Publications 2022

Brobak KM, Andreassen RM, Melsom T, Høieggen A, Norvik JV, Solbu MD (2022)
Associations of urinary orosomucoid, N-acetyl-β-D-glucosaminidase, and albumin with blood pressure and hypertension after 7 years. The Tromsø Study
Blood Press, 31 (1), 270-283
DOI 10.1080/08037051.2022.2128043, PubMed 36193001

Halvorsen LV, Bergland OU, Søraas CL, Larstorp ACK, Hjørnholm U, Kjær VN, Kringen MK, Clasen PE, Haldsrud R, Kjeldsen SE, Rostrup M, Fadl Elmula FEM, Opdal MS, Høieggen A (2022)
Nonadherence by Serum Drug Analyses in Resistant Hypertension: 7-Year Follow-Up of Patients Considered Adherent by Directly Observed Therapy
J Am Heart Assoc, 11 (18), e025879
DOI 10.1161/JAHA.121.025879, PubMed 36073648

Thorstensen CW, Clasen PE, Rognstad S, Haldsrud R, Føreid S, Helstrøm T, Bergland OU, Halvorsen LV, Aune A, Olsen E, Brobak KM, Høieggen A, Gustavsen I, Larstorp ACK, Søraas CL, Opdal MS (2022)
Development of UHPLC-MS/MS methods to quantify 25 antihypertensive drugs in serum in a cohort of patients treated for hypertension
J Pharm Biomed Anal, 219, 114908
DOI 10.1016/j.jpba.2022.114908, PubMed 35803015

Publications 2021

Bergland OU, Halvorsen LV, Søraas CL, Hjørnholm U, Kjær VN, Rognstad S, Brobak KM, Aune A, Olsen E, Fauchald YM, Heimark S, Thorstensen CW, Liestøl K, Solbu MD, Gerdts E, Mo R, Rostrup M, Kjeldsen SE, Høieggen A, Opdal MS, Larstorp ACK, Fadl Elmula FEM (2021)
Detection of Nonadherence to Antihypertensive Treatment by Measurements of Serum Drug Concentrations
Hypertension, 78 (3), 617-628
DOI 10.1161/HYPERTENSIONAHA.121.17514, PubMed 34275336

Rognstad S, Søraas CL, Bergland OU, Høieggen A, Strømmen M, Helland A, Opdal MS (2021)
Establishing Serum Reference Ranges for Antihypertensive Drugs
Ther Drug Monit, 43 (1), 116-125
DOI 10.1097/FTD.0000000000000806, PubMed 32881780

Undrum Bergland O, Larstorp ACK, Lund Søraas C, Høieggen A, Rostrup M, Norheim Kjaer V, Godang K, Sevre K, Fadl Elmula FEM (2021)
Changes in sympathetic nervous system activity after renal denervation: results from the randomised Oslo RDN study
Blood Press, 30 (3), 154-164
DOI 10.1080/08037051.2020.1868286, PubMed 33399016

Publications 2020

Bergland OU, Søraas CL, Larstorp ACK, Halvorsen LV, Hjørnholm U, Hoffman P, Høieggen A, Fadl Elmula FEM (2020)
The randomised Oslo study of renal denervation vs. Antihypertensive drug adjustments: efficacy and safety through 7 years of follow-up
Blood Press, 30 (1), 41-50
DOI 10.1080/08037051.2020.1828818, PubMed 33030064

Bergo KK, Larstorp AC, Hoffmann P, Hjørnholm U, Cataliotti A, Høieggen A, Rostrup M, Fadl Elmula FEM (2020)
Renal sympathetic denervation lowers systemic vascular resistance in true treatment-resistant hypertension
Blood Press, 30 (1), 31-40
DOI 10.1080/08037051.2020.1789446, PubMed 32633141

Publications 2019

Drangsholt SH, Cappelen UW, von der Lippe N, Høieggen A, Os I, Brekke FB (2019)
Beliefs about medicines in dialysis patients and after renal transplantation
Hemodial Int, 23 (1), 117-125
DOI 10.1111/hdi.12717, PubMed 30714322

Hjørnholm U, Larstorp ACK, Andersen MH, Høieggen A (2019)
Directly observed therapy prior to ambulatory blood pressure measurement (DOT-HTN) in uncontrolled hypertensive patients - Effect on blood pressure, safety and patient perception
Blood Press, 28 (5), 327-335
DOI 10.1080/08037051.2019.1633907, PubMed 31250668

Sommer M, von der Lippe N, Klow NE, Hoieggen A (2019)
Renal fibromuscular dysplasia and hypertension
Tidsskr. Nor. Laegeforen., 139 (4), 342-345

Sommer M, von der Lippe N, Kløw NE, Høieggen A (2019)
[Renal fibromuscular dysplasia and hypertension]
Tidsskr Nor Laegeforen, 139 (4)
DOI 10.4045/tidsskr.18.0226, PubMed 30808101

Sommer M, von der Lippe N, Kløw NE, Høieggen A (2019)
[M. Sommer and colleagues respond]
Tidsskr Nor Laegeforen, 139 (8)
DOI 10.4045/tidsskr.19.0273, PubMed 31062566

Stubnova V, Os I, Høieggen A, Solbu MD, Grundtvig M, Westheim AS, Atar D, Waldum-Grevbo B (2019)
Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure
BMC Cardiovasc Disord, 19 (1), 4
DOI 10.1186/s12872-018-0989-8, PubMed 30611196

Publications 2017

Mariampillai JE, Eskås PA, Heimark S, Larstorp AC, Fadl Elmula FE, Høieggen A, Nortvedt P (2017)
Apparent treatment-resistant hypertension - patient-physician relationship and ethical issues
Blood Press, 26 (3), 133-138
DOI 10.1080/08037051.2016.1277129, PubMed 28078909

Publications 2016

Berra E, Azizi M, Capron A, Høieggen A, Rabbia F, Kjeldsen SE, Staessen JA, Wallemacq P, Persu A (2016)
Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension
Hypertension, 68 (2), 297-306
DOI 10.1161/HYPERTENSIONAHA.116.07464, PubMed 27296995

Eskas PA, Heimark S, Mariampillai JE, Larstorp ACK, Elmula FEMF, Hoieggen A (2016)
Drug compliance and monitoring of antihypertensive treatment
Tidsskr. Nor. Laegeforen., 136 (10), 920-923

Eskås PA, Heimark S, Eek Mariampillai J, Larstorp AC, Fadl Elmula FE, Høieggen A (2016)
Adherence to medication and drug monitoring in apparent treatment-resistant hypertension
Blood Press, 25 (4), 199-205
DOI 10.3109/08037051.2015.1121706, PubMed 26729283

Eskås PA, Heimark S, Mariampillai JE, Larstorp AC, Fadl Elmula FE, Høieggen A (2016)
[Medication adherence and monitoring of antihypertensive treatment]
Tidsskr Nor Laegeforen, 136 (10), 920-3
DOI 10.4045/tidsskr.15.0978, PubMed 27272370

Heimark S, Eskås PA, Mariampillai JE, Larstorp AC, Høieggen A, Fadl Elmula FE (2016)
Tertiary work-up of apparent treatment-resistant hypertension
Blood Press, 25 (5), 312-8
DOI 10.3109/08037051.2016.1172865, PubMed 27124769

Publications 2015

Persu A, Jin Y, Fadl Elmula FE, Renkin J, Høieggen A, Kjeldsen SE, Staessen JA (2015)
Renal denervation in treatment-resistant hypertension: a reappraisal
Curr Opin Pharmacol, 21, 48-52
DOI 10.1016/j.coph.2014.12.013, PubMed 25601357

Skårn SN, Flaa A, Kjeldsen SE, Rostrup M, Brunborg C, Reims HM, Fossum E, Høieggen A, Aksnes TA (2015)
High screening blood pressure at young age predicts future masked hypertension: A 17 year follow-up study
Blood Press, 24 (3), 131-8
DOI 10.3109/21695717.2015.1030889, PubMed 25901999

Skårn SN, Flaa A, Kjeldsen SE, Rostrup M, Brunborg C, Reims HM, Fossum E, Høieggen A, Aksnes TA (2015)
Family history of hypertension and serum triglycerides predict future insulin sensitivity: a 17-year follow-up study of young men
J Hypertens, 33 (9), 1845-51; discussion 1852
DOI 10.1097/HJH.0000000000000632, PubMed 26103130

Publications 2014

Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A (2014)
Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension
Hypertension, 63 (5), 991-9
DOI 10.1161/HYPERTENSIONAHA.114.03246, PubMed 24591332

Kjeldsen SE, Sørensen H, Fadl Elmula FE, Brekke M, Gjønnæss E, Hjørnholm U, Kjære VN, Rostrup M, Fossum E, Os I, Stenehjem A, Høieggen A, Hoffmann P (2014)
[Re: Renal sympathetic denervation in treatment-resistant hypertension]
Tidsskr Nor Laegeforen, 134 (15), 1449-50
DOI 10.4045/tidsskr.14.0931, PubMed 25138398

Mariampillai JE, Fadl Elmula FE, Hoffmann P, Sørensen H, Høieggen A, Kjeldsen SE (2014)
[Questionable efficacy of renal denervation]
Tidsskr Nor Laegeforen, 134 (17), 1643-4
DOI 10.4045/tidsskr.14.0900, PubMed 25223668

Sørensen H, Fadl Elmula FE, Kjeldsen SE, Brekke M, Gjønnæss E, Hjørnholm U, Kjær VN, Rostrup M, Fossum E, Os I, Stenehjem A, Høieggen A, Hoffmann P (2014)
[Renal sympathetic denervation in treatment-resistant hypertension]
Tidsskr Nor Laegeforen, 134 (1), 32-6
DOI 10.4045/tidsskr.13.0276, PubMed 24429753

Publications 2013

Fadl Elmula FE, Hoffmann P, Fossum E, Brekke M, Gjønnæss E, Hjørnholm U, Kjær VN, Rostrup M, Kjeldsen SE, Os I, Stenehjem AE, Høieggen A (2013)
Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure
Hypertension, 62 (3), 526-32
DOI 10.1161/HYPERTENSIONAHA.113.01452, PubMed 23836798

Kjeldsen SE, Schultz M, Vinkenes K, Aksnes TA, Høieggen A (2013)
[Blood Pressure Treatment--towards consensus on many things]
Tidsskr Nor Laegeforen, 133 (21), 2226
DOI 10.4045/tidsskr.13.1374, PubMed 24226313

Schultz M, Aksnes TA, Høieggen A, Kjeldsen SE (2013)
[Choice of drug in hypertension]
Tidsskr Nor Laegeforen, 133 (17), 1802-3
DOI 10.4045/tidsskr.13.0311, PubMed 24042290

Publications 2012

Gudmundsdottir H, Høieggen A, Stenehjem A, Waldum B, Os I (2012)
Hypertension in women: latest findings and clinical implications
Ther Adv Chronic Dis, 3 (3), 137-46
DOI 10.1177/2040622312438935, PubMed 23251774

Høieggen A, Os I (2012)
[Kidney injuries caused by drugs]
Tidsskr Nor Laegeforen, 132 (12-13), 1462-4
DOI 10.4045/tidsskr.11.0773, PubMed 22766820

Høieggen A, Os I (2012)
[Serious illness--tough treatment]
Tidsskr Nor Laegeforen, 132 (14), 1624-5
DOI 10.4045/tidsskr.12.0424, PubMed 22875129

Publications 2010

Wiik BP, Larstorp AC, Høieggen A, Kjeldsen SE, Olsen MH, Ibsen H, Lindholm L, Dahlöf B, Devereux RB, Okin PM, Wachtell K (2010)
Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The LIFE Study
Am J Hypertens, 23 (8), 845-51
DOI 10.1038/ajh.2010.89, PubMed 20431530

Publications 2009

Gudmundsdottir H, Taarnhøj NC, Strand AH, Kjeldsen SE, Høieggen A, Os I (2009)
Blood pressure development and hypertensive retinopathy: 20-year follow-up of middle-aged normotensive and hypertensive men
J Hum Hypertens, 24 (8), 505-13
DOI 10.1038/jhh.2009.94, PubMed 20010619

Publications 2008

Gudmundsdottir H, Strand AH, Høieggen A, Reims HM, Westheim AS, Eide IK, Kjeldsen SE, Os I (2008)
Do screening blood pressure and plasma catecholamines predict development of hypertension? Twenty-year follow-up of middle-aged men
Blood Press, 17 (2), 94-103
DOI 10.1080/08037050801972923, PubMed 18568698

Gudmundsdottir H, Strand AH, Kjeldsen SE, Høieggen A, Os I (2008)
Serum phosphate, blood pressure, and the metabolic syndrome--20-year follow-up of middle-aged men
J Clin Hypertens (Greenwich), 10 (11), 814-21
DOI 10.1111/j.1751-7176.2008.00032.x, PubMed 19128269

Publications 2007

Aksnes TA, Seljeflot I, Torjesen PA, Höieggen A, Moan A, Kjeldsen SE (2007)
Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity
Metabolism, 56 (11), 1470-7
DOI 10.1016/j.metabol.2007.06.012, PubMed 17950096

Kjeldsen SE, Lyle PA, Kizer JR, Oparil S, Høieggen A, Os I (2007)
Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke
Vasc Health Risk Manag, 3 (3), 299-305
PubMed 17703637

Smebye ML, Iversen EK, Høieggen A, Flaa A, Os I, Kjeldsen SE, Olsen MH, Chattopadhyay A, Hille DA, Lyle PA, Devereux RB, Dahlöf B (2007)
Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study)
Am J Cardiol, 100 (5), 855-9
DOI 10.1016/j.amjcard.2007.03.109, PubMed 17719333

Strand A, Gudmundsdottir H, Høieggen A, Fossum E, Bjørnerheim R, Os I, Kjeldsen SE (2007)
Increased hematocrit before blood pressure in men who develop hypertension over 20 years
J Am Soc Hypertens, 1 (6), 400-6
DOI 10.1016/j.jash.2007.07.002, PubMed 20409872

Publications 2006

Fossum E, Olsen MH, Høieggen A, Wachtell K, Reims HM, Kjeldsen SE, Ibsen H, Wan Y, Julius S (2006)
Long-term effects of a losartan- compared with an atenolol-based treatment regimen on carotid artery plaque development in hypertensive patients with left ventricular hypertrophy: ICARUS, a LIFE substudy
J Clin Hypertens (Greenwich), 8 (3), 169-73
DOI 10.1111/j.1524-6175.2006.04838.x, PubMed 16522993

Narayan P, Papademetriou V, Wachtell K, Gerdts E, Boman K, Nieminen MS, de Simone G, Dahlöf B, Fyhrquist F, Hoieggen A, Devereux RB (2006)
Association of hemoglobin delivery with left ventricular structure and function in hypertensive patients: Losartan Intervention for End Point Reduction in Hypertension Study
Hypertension, 47 (5), 868-73
DOI 10.1161/01.HYP.0000215578.40687.6f, PubMed 16567586

Tonstad S, Klemsdal TO, Landaas S, Høieggen A (2006)
No effect of increased water intake on blood viscosity and cardiovascular risk factors
Br J Nutr, 96 (6), 993-6
DOI 10.1017/bjn20061969, PubMed 17181872

Publications 2005

Høieggen A, Os I, Kjeldsen SE (2005)
[Uric acid--more deleterious than we thought?]
Tidsskr Nor Laegeforen, 125 (10), 1330-2
PubMed 15909004

Kjeldsen SE, Os I, Høieggen A, Beckey K, Gleim GW, Oparil S (2005)
Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide
Am J Cardiovasc Drugs, 5 (1), 17-22
DOI 10.2165/00129784-200505010-00003, PubMed 15631534

Olsen MH, Fossum E, Høieggen A, Wachtell K, Hjerkinn E, Nesbitt SD, Andersen UB, Phillips RA, Gaboury CL, Ibsen H, Kjeldsen SE, Julius S (2005)
Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy
J Hypertens, 23 (4), 891-8
DOI 10.1097/01.hjh.0000163160.60234.15, PubMed 15775796

Reims HM, Sevre K, Høieggen A, Fossum E, Eide I, Kjeldsen SE (2005)
Blood viscosity: effects of mental stress and relations to autonomic nervous system function and insulin sensitivity
Blood Press, 14 (3), 159-69
DOI 10.1080/08037050510034176, PubMed 16036496

Publications 2004

Fossum E, Høieggen A, Reims HM, Moan A, Rostrup M, Eide I, Kjeldsen SE (2004)
High screening blood pressure is related to sympathetic nervous system activity and insulin resistance in healthy young men
Blood Press, 13 (2), 89-94
DOI 10.1080/08037050310031008, PubMed 15182111

Fossum E, Olsen MH, Høieggen A, Wachtell K, Reims HM, Ibsen H, Julius S, Kjeldsen SE (2004)
Long-term plasma catecholamines in patients with hypertension and left ventricular hypertrophy treated with losartan or atenolol: ICARUS, a LIFE substudy
J Hum Hypertens, 18 (6), 375-80
DOI 10.1038/sj.jhh.1001712, PubMed 15057253

Høieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Chen C, Dahlöf B, LIFE Study Group (2004)
The impact of serum uric acid on cardiovascular outcomes in the LIFE study
Kidney Int, 65 (3), 1041-9
DOI 10.1111/j.1523-1755.2004.00484.x, PubMed 14871425

Os I, Oparil S, Gerdts E, Høieggen A (2004)
Essential hypertension in women
Blood Press, 13 (5), 272-8
DOI 10.1080/08037050410024330, PubMed 15545149

Reims HM, Fossum E, Høieggen A, Moan A, Eide I, Kjeldsen SE (2004)
Adrenal medullary overactivity in lean, borderline hypertensive young men
Am J Hypertens, 17 (7), 611-8
DOI 10.1016/j.amjhyper.2004.03.676, PubMed 15233980

Reims HM, Sevre K, Fossum E, Høieggen A, Eide I, Kjeldsen SE (2004)
Plasma catecholamines, blood pressure responses and perceived stress during mental arithmetic stress in young men
Blood Press, 13 (5), 287-94
DOI 10.1080/08037050410016474, PubMed 15545152

Reims HM, Sevre K, Fossum E, Høieggen A, Mellem H, Kjeldsen SE (2004)
Relations between insulin sensitivity, fitness and autonomic cardiac regulation in healthy, young men
J Hypertens, 22 (10), 2007-15
DOI 10.1097/00004872-200410000-00025, PubMed 15361774

Publications 2003

Höieggen A, Fossum E, Reims H, Kjeldsen SE (2003)
Serum uric acid and hemorheology in borderline hypertensives and in subjects with established hypertension and left ventricular hypertrophy
Blood Press, 12 (2), 104-10
DOI 10.1080/08037050310060508, PubMed 12797630

Kjeldsen SE, Fossum E, Reims HM, Høieggen A (2003)
Hypertension treatment and stroke prevention
Blood Press, 12 (5-6), 264-8
DOI 10.1080/08037050310016501, PubMed 14763656

Midtvedt K, Fauchald P, Bergan S, Høieggen A, Hallan S, Svarstad E, Bergrem H, Eriksen BO, Pfeffer PF, Dalen I, Leivestad T (2003)
C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
Transplantation, 76 (8), 1236-8
DOI 10.1097/01.TP.0000085046.39523.D5, PubMed 14578761

Olsen MH, Hjerkinn E, Wachtell K, Høieggen A, Bella JN, Nesbitt SD, Fossum E, Kjeldsen SE, Julius S, Ibsen H (2003)
Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy
J Hum Hypertens, 17 (5), 305-11
DOI 10.1038/sj.jhh.1001545, PubMed 12756402

Os I, Fredheim CS, Draganov B, Høieggen A, Andersson KS (2003)
[Acute renal failure during the treatment of heart failure with ACE inhibitors]
Tidsskr Nor Laegeforen, 123 (1), 30-2
PubMed 12600146

Os I, Høieggen A, Larsen A, Sandset PM, Djurovic S, Berg K, Os A, Birkeland K, Westheim A (2003)
Smoking and relation to other risk factors in postmenopausal women with coronary artery disease, with particular reference to whole blood viscosity and beta-cell function
J Intern Med, 253 (2), 232-9
DOI 10.1046/j.1365-2796.2003.01110.x, PubMed 12542565

Os I, Høieggen A, Larsen A, Sandset PM, Djurovic S, Berg K, Os A, Birkeland KI, Westheim A (2003)
Smoking and relation to other risk factors in postmenopausal women with coronary artery disease, with particular reference to whole blood viscosity and beta-cell function
In Journal of internal medicine, Blackwell Scientific Publ., Oxford, 253(2003)2, s.232-9
BIBSYS 041722221

Publications 2002

Jonsson G, Fossum E, Kjeldsen SE, Høieggen A, Os I, Eide I, Westheim A (2002)
Lower plasma noradrenaline and blood viscosity on carvedilol vs atenolol in men with recent myocardial infarction
Blood Press, 11 (6), 377-84
DOI 10.1080/080370502321095357, PubMed 12523682

Os I, Stenehjem A, Høieggen A, Draganov B, Jenssen T, Holdaas H (2002)
[Type 2 diabetes and nephropathy--new studies, new treatment strategies?]
Tidsskr Nor Laegeforen, 122 (9), 918-20
PubMed 12082835

Publications 2001

Fossum E, Berge KE, Høieggen A, Moan A, Rostrup M, Kjeldsen SE, Eide I, Berg K (2001)
Polymorphisms in candidate genes for blood pressure regulation in young men with normal or elevated screening blood pressure
Blood Press, 10 (2), 92-100
DOI 10.1080/08037050152112078, PubMed 11467765

Høieggen A (2001)
Whole blood viscosity, sympathetic activity and insulin effects: studies in borderline hypertensive young men and in established hypertensive patients
University of Oslo, [Oslo], 1 b. (flere pag.)
BIBSYS 011094087, ISBN 82-497-0029-5

Høieggen A, Draganov B, Os I (2001)
[Bilateral renal artery stenosis--a cause of acute pulmonary edema]
Tidsskr Nor Laegeforen, 121 (15), 1789-90
PubMed 11464682

Høieggen A, Fossum E, Moan A, Rostrup M, Eide IK, Kjeldsen SE (2001)
Biphasic effect of epinephrine on blood glucose during hyperinsulinemia in borderline hypertensive young men
Am J Hypertens, 14 (6 Pt 1), 539-45
DOI 10.1016/s0895-7061(00)01306-6, PubMed 11411733

Reims HM, Høieggen A, Fossum E, Rostrup M, Eide I, Kjeldsen SE (2001)
Glucose disposal rates calculated from 60- to 90-minute isoglycemic hyperinsulinemic glucose clamp correlate with cardiovascular risk factors in borderline hypertensive young men
Metabolism, 50 (10), 1175-80
DOI 10.1053/meta.2001.26761, PubMed 11586489

Ross AE, Flaa A, Høieggen A, Reims H, Eide IK, Kjeldsen SE (2001)
Gender specific sympathetic and hemorrheological responses to mental stress in healthy young subjects
Scand Cardiovasc J, 35 (5), 307-12
DOI 10.1080/140174301317116271, PubMed 11771821

Publications 2000

Belkić K, Schwartz J, Schnall P, Pickering TG, Steptoe A, Marmot M, Theorell T, Fossum E, Høieggen A, Moan A, Rostrup M, Kjeldsen SE (2000)
Evidence for mediating econeurocardiologic mechanisms
Occup Med, 15 (1), 117-62
PubMed 10620789

Høieggen A, Fossum E, Moan A, Rostrup M, Eide IK, Kjeldsen SE (2000)
Effects of hyperinsulinemia on sympathetic responses to mental stress
Am J Hypertens, 13 (1 Pt 1), 21-8
DOI 10.1016/s0895-7061(99)00146-6, PubMed 10678267

Høieggen A, Fossum E, Nesbitt SD, Palmieri V, Kjeldsen SE (2000)
Blood viscosity, plasma adrenaline and fasting insulin in hypertensive patients with left ventricular hypertrophy. ICARUS, a LIFE Substudy. Insulin CARotids US Scandinavica
Blood Press, 9 (2-3), 83-90
DOI 10.1080/08037050050151771, PubMed 10855729

Olsen MH, Fossum E, Hjerkinn E, Wachtell K, Høieggen A, Nesbitt SD, Andersen UB, Phillips RA, Gaboury CL, Ibsen H, Kjeldsen SE, Julius S (2000)
Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE sub study. Insulin Carotids US Scandinavia
J Hypertens, 18 (1), 75-81
DOI 10.1097/00004872-200018010-00011, PubMed 10678546

Reims H, Høieggen A, Fossum E, Kjeldsen SE (2000)
Assessment of insulin sensitivity by 90 min isoglycaemic hyperinsulinaemic glucose clamp in healthy young men
Blood Press, 9 (2-3), 121-5
DOI 10.1080/080370500453456, PubMed 10855735

Publications 1999

Fossum E, Høieggen A, Moan A, Rostrup M, Kjeldsen SE (1999)
Insulin sensitivity is related to physical fitness and exercise blood pressure to structural vascular properties in young men
Hypertension, 33 (3), 781-6
DOI 10.1161/01.hyp.33.3.781, PubMed 10082487

Høieggen A, Fossum E, Moan A, Rostrup M, Eide IK, Kjeldsen SE (1999)
Increased forearm blood flow during glucose clamp is related neither to insulin sensitivity nor to hyperinsulinemia in borderline hypertensive young men
Blood Press, 8 (4), 227-32
DOI 10.1080/080370599439616, PubMed 10697303

Publications 1998

Fossum E, Høieggen A, Moan A, Rostrup M, Nordby G, Kjeldsen SE (1998)
Relationship between insulin sensitivity and maximal forearm blood flow in young men
Hypertension, 32 (5), 838-43
DOI 10.1161/01.hyp.32.5.838, PubMed 9822441

Høieggen A, Fossum E, Moan A, Eide IK, Kjeldsen SE (1998)
Insulin modifies the glucose response to mental stress independently of forearm blood flow
Blood Press, 7 (5-6), 291-8
DOI 10.1080/080370598437150, PubMed 10321442

Høieggen A, Fossum E, Moan A, Enger E, Kjeldsen SE (1998)
Whole-blood viscosity and the insulin-resistance syndrome
J Hypertens, 16 (2), 203-10
DOI 10.1097/00004872-199816020-00011, PubMed 9535148

Publications 1997

Fossum E, Høieggen A, Moan A, Nordby G, Kjeldsen SE (1997)
Insulin sensitivity relates to other cardiovascular risk factors in young men: validation of some modifications of the hyperinsulinaemic, isoglycaemic glucose clamp technique
Blood Press Suppl, 2, 113-9
PubMed 9495639

Fossum E, Høieggen A, Moan A, Nordby G, Velund TL, Kjeldsen SE (1997)
Whole blood viscosity, blood pressure and cardiovascular risk factors in healthy blood donors
Blood Press, 6 (3), 161-5
DOI 10.3109/08037059709061932, PubMed 9181254

Publications 1996

Moan A, Høieggen A, Seljeflot I, Risanger T, Arnesen H, Kjeldsen SE (1996)
The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity
J Hypertens, 14 (9), 1093-7
DOI 10.1097/00004872-199609000-00008, PubMed 8986909

Publications 1995

Moan A, Høieggen A, Nordby G, Birkeland K, Eide I, Kjeldsen SE (1995)
The glucose clamp procedure activates the sympathetic nervous system even in the absence of hyperinsulinemia
J Clin Endocrinol Metab, 80 (11), 3151-4
DOI 10.1210/jcem.80.11.7593418, PubMed 7593418

Moan A, Høieggen A, Nordby G, Eide IK, Kjeldsen SE (1995)
Effects of losartan on insulin sensitivity in severe hypertension: connections through sympathetic nervous system activity?
J Hum Hypertens, 9 Suppl 5, S45-50
PubMed 8583481

Moan A, Høieggen A, Nordby G, Os I, Eide I, Kjeldsen SE (1995)
Mental stress increases glucose uptake during hyperinsulinemia: associations with sympathetic and cardiovascular responsiveness
Metabolism, 44 (10), 1303-7
DOI 10.1016/0026-0495(95)90034-9, PubMed 7476289

Publications 1994

Høieggen A, Enger E (1994)
[Rhabdomyolysis and physical activity]
Tidsskr Nor Laegeforen, 114 (11), 1299-300
PubMed 8079206

Publications 1992

Høieggen A (1992)
[Treatment of arthritis urica and hyperuricemia]
Tidsskr Nor Laegeforen, 112 (8), 1038-40
PubMed 1553729